Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) went down by -20.44% from its latest closing price compared to the recent 1-year high of $6.15. The company’s stock price has collected -34.67% of loss in the last five trading sessions.
Is It Worth Investing in Pieris Pharmaceuticals Inc. (NASDAQ :PIRS) Right Now?
Plus, the 36-month beta value for PIRS is at 1.14. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Pieris Pharmaceuticals Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $8.00, which is $6.21 above the current price. PIRS currently public float of 66.78M and currently shorts hold a 1.08% ratio of that float. Today, the average trading volume of PIRS was 406.43K shares.
PIRS’s Market Performance
PIRS stocks went down by -34.67% for the week, with a monthly drop of -42.44% and a quarterly performance of -48.86%, while its annual performance rate touched 0.00%. The volatility ratio for the week stands at 12.26% while the volatility levels for the past 30 days are set at 6.64% for Pieris Pharmaceuticals Inc.. The simple moving average for the period of the last 20 days is -37.51% for PIRS stocks with a simple moving average of -52.71% for the last 200 days.
Analysts’ Opinion of PIRS
Many brokerage firms have already submitted their reports for PIRS stocks, with Robert W. Baird repeating the rating for PIRS by listing it as a “Outperform.” The predicted price for PIRS in the upcoming period, according to Robert W. Baird is $5 based on the research report published on March 13th of the previous year 2020.
Robert W. Baird gave a rating of “Outperform” to PIRS, setting the target price at $5 in the report published on May 14th of the previous year.
PIRS Trading at -40.14% from the 50-Day Moving Average
After a stumble in the market that brought PIRS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.89% of loss for the given period.
Volatility was left at 6.64%, however, over the last 30 days, the volatility rate increased by 12.26%, as shares sank -41.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -41.69% lower at present.
During the last 5 trading sessions, PIRS fell by -34.67%, which changed the moving average for the period of 200-days by -46.57% in comparison to the 20-day moving average, which settled at $2.80. In addition, Pieris Pharmaceuticals Inc. saw -52.65% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at PIRS starting from Olwill Shane, who sale 38,400 shares at the price of $5.11 back on Aug 30. After this action, Olwill Shane now owns 4,638 shares of Pieris Pharmaceuticals Inc., valued at $196,380 using the latest closing price.
Stock Fundamentals for PIRS
Current profitability levels for the company are sitting at:
- -164.97 for the present operating margin
- +92.46 for the gross margin
The net margin for Pieris Pharmaceuticals Inc. stands at -145.58. Equity return is now at value -96.50, with -31.10 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.52.